S2-E25.2 – Prevalence of NAFLD and NASH 2021 — Deeper Dive

Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gawrieh in a deeper dive into key findings from the 2021 Journal of Hepatology paper titled "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort."

A deeper dive into the data coming from the 2021 Journal of Hepatology paper “Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort” reveals several troubling trends, including percentages of patients with F2/F3 NASH increasing far faster than the overall NAFLD rate and population subgroups where a majority of the patients in this study exhibited NAFLD and over 1/3 exhibited NASH. Whether you are familiar with the paper or not, you will want to listen to this conversation to hear points you might have missed.

TOPICS: AASLD, COVID-19, Diabetes, Diagnostic Tests, EchoSens, education, Fibrosis Level 3, Lean NASH, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Obesity, Perspectum Diagnostics, population screening, social policy, Fibrosis Level 2, Epidemiology, San Antonia Military Medical Center,

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Request A Transcript of This Episode
Request Transcript
First
Last

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"